T, 260 mg/m2, paclitaxel for injection (albumin-bound)
HY-PA023-001
Unknown small_molecule active
Quick answer
T, 260 mg/m2, paclitaxel for injection (albumin-bound) for Breast Cancer is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Breast Cancer
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active